Maintenance Lenalidomide for Adults Aged 18-65 Years with AML in First Complete Remission after Intensive Chemotherapy: A Phase Ib Dose-Escalation Study of the Australasian Leukemia and Lymphoma Group (ALLG)
暂无分享,去创建一个
I. Lewis | A. Wei | A. Enjeti | J. Seymour | U. Hahn | M. Hertzberg | S. He | P. Campbell | G. Cull